Skip to main content
Log in

Pediatric recurrent Rosai-Dorfman disease with germline heterozygous SLC29A3 and somatic MAP2K1 mutations

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Data Availability

Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.

References

  1. Garces S, Medeiros LJ, Patel KP, Li S, Pina-Oviedo S, Li J, Garces JC, Khoury JD, Yin CC (2017) Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai–Dorfman disease. Mod Pathol 30(10):1367–1377

    Article  CAS  Google Scholar 

  2. Savaşan S, Al-Qanber B, Buck S, Wakeling E, Gadgeel M (2020) Clonal T-cell large granular lymphocyte proliferations in childhood and young adult immune dysregulation conditions. Pediatr Blood Cancer 67(5):e28231

    Article  Google Scholar 

  3. Maric I, Pittaluga S, Dale JK, Niemela JE, Delsol G, Diment J, Rosai J, Raffeld M, Puck JM, Straus SE, Jaffe ES (2005) Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome. Am J Surg Pathol 29(7):903–911

    Article  Google Scholar 

  4. Morgan NV, Morris MR, Cangul H et al (2010) Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman disease. PLoS Genetics 6(2):e1000833

  5. Rossbach H-C, Dalence C, Wynn T, Tebbi C (2006) Faisalabad histiocytosis mimics Rosai-Dorfman disease: brothers with lymphadenopathy, intrauterine fractures, short stature, and sensorineural deafness. Pediatr Blood Cancer 47(5):629–632

    Article  Google Scholar 

  6. Sloan J, Johnston J, Manoli I et al (2011) Exome sequencing identifies ACSF3 as a cause of combined malonic and methylmalonic aciduria. Nat Genet 43(9):883–886

    Article  CAS  Google Scholar 

  7. Haroche J, Charlotte F, Arnaud L, von Deimling A, Hélias-Rodzewicz Z, Hervier B, Cohen-Aubart F, Launay D, Lesot A, Mokhtari K, Canioni D, Galmiche L, Rose C, Schmalzing M, Croockewit S, Kambouchner M, Copin MC, Fraitag S, Sahm F, Brousse N, Amoura Z, Donadieu J, Emile JF (2012) High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. Blood. 120(13):2700–2703

    Article  CAS  Google Scholar 

  8. Zeng K, Ohshima K, Liu Y et al (2016) BRAFV600E and MAP2K1 mutations in Langerhans cell histiocytosis occur predominantly in children. Hematol Oncol 35(4):845–851

    Article  Google Scholar 

  9. Melki I, Lambot K, Jonard L, Couloigner V, Quartier P, Neven B, Bader-Meunier B (2013) Mutation in the SLC29A3 gene: a new cause of a monogenic, autoinflammatory condition. Pediatrics. 131(4):e1308–e1313

    Article  Google Scholar 

  10. Chela James, Simon Eaton, Paul Brogan, Khalid Hussain (2011) Pigmented hypertrichosis and insulin dependent diabetes mellitus (PHID) syndrome is associated with chronic inflammation and involves the NF-kB response pathway of inflammation. Presented at Society for Endocrinology BES 2017, London, UK. Endocrine Abstracts 27 P56

Download references

Acknowledgments

This case has been submitted for presentation at the Histiocyte Society meeting in 2020.

Author information

Authors and Affiliations

Authors

Contributions

The manuscript was drafted by Shruthi Suryaprakash; edited by Amy George and Scott Langenburg; and was planned, drafted, and edited by Süreyya Savaşan.

Corresponding author

Correspondence to Süreyya Savaşan.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

Ethics approval was not required for this case report.

Consent to participate

Photography consent was obtained from the legal guardian.

Consent for publication

Photography consent was obtained from the legal guardian.

Code availability

Code availability is not applicable as no codes were used in the current study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Suryaprakash, S., George, A., Langenburg, S. et al. Pediatric recurrent Rosai-Dorfman disease with germline heterozygous SLC29A3 and somatic MAP2K1 mutations. Ann Hematol 99, 2965–2967 (2020). https://doi.org/10.1007/s00277-020-04264-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-020-04264-3

Navigation